{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T19:27:37Z","timestamp":1790537257305,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.atherosclerosis.2011.11.005","type":"journal-article","created":{"date-parts":[[2011,11,17]],"date-time":"2011-11-17T16:18:10Z","timestamp":1321546690000},"page":"15-21","source":"Crossref","is-referenced-by-count":69,"title":["Statins as a possible cause of inflammatory and necrotizing myopathies"],"prefix":"10.1016","volume":"222","author":[{"given":"Santosh","family":"Padala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul D.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"December (6)","key":"10.1016\/j.atherosclerosis.2011.11.005_bib0005","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s10557-005-5686-z","article-title":"Mild to moderate muscular symptoms with high-dose statin therapy in hyperlipidemic patients \u2013 the PRIMO study","volume":"19","author":"Bruckert","year":"2005","journal-title":"Cardiovasc Drugs Ther"},{"issue":"June (4)","key":"10.1016\/j.atherosclerosis.2011.11.005_bib0010","first-page":"1438","article-title":"Myopathy associated with HMG-CoA reductase inhibitors (statins): a series of 10 patients and review of the literature","volume":"3","author":"McKelvie","year":"2002","journal-title":"J Clin Neuromuscul Dis"},{"issue":"December (22)","key":"10.1016\/j.atherosclerosis.2011.11.005_bib0015","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1001\/archinte.165.22.2671","article-title":"Outcomes in 45 patients with statin-associated myopathy","volume":"165","author":"Hansen","year":"2005","journal-title":"Arch Intern Med"},{"issue":"May (9065)","key":"10.1016\/j.atherosclerosis.2011.11.005_bib0020","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1016\/S0140-6736(05)61628-5","article-title":"Polymyositis associated with simvastatin","volume":"349","author":"Giordano","year":"1997","journal-title":"Lancet"},{"issue":"November (10)","key":"10.1016\/j.atherosclerosis.2011.11.005_bib0025","first-page":"934","article-title":"Severe polymyositis with simvastatin use","volume":"37","author":"Riesco-Eizaguirre","year":"2003","journal-title":"Rev Neurol"},{"issue":"January (1)","key":"10.1016\/j.atherosclerosis.2011.11.005_bib0030","first-page":"25","article-title":"Pravastatin-associated polymyositis, a case report","volume":"44","author":"Takagi","year":"2004","journal-title":"Rinsho Shinkeigaku"},{"issue":"April (4)","key":"10.1016\/j.atherosclerosis.2011.11.005_bib0035","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.revmed.2003.10.013","article-title":"Polymyositis induced or associated with lipid-lowering drugs: five cases","volume":"25","author":"Fauchais","year":"2004","journal-title":"Rev Med Intern"},{"key":"10.1016\/j.atherosclerosis.2011.11.005_bib0040","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1136\/ard.2007.075523","article-title":"Increased exposure to statins in patients developing chronic muscle diseases: a 2-year retrospective study","volume":"67","author":"Sailler","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"August (9)","key":"10.1016\/j.atherosclerosis.2011.11.005_bib0045","first-page":"649","article-title":"Pravastatin-associated inflammatory myopathy","volume":"327","author":"Schalke","year":"1992","journal-title":"N Engl J Med"},{"issue":"February (2)","key":"10.1016\/j.atherosclerosis.2011.11.005_bib0050","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/rheumatology\/33.2.199","article-title":"Simvastatin-associated dermatomyositis","volume":"33","author":"Khattak","year":"1994","journal-title":"Br J Rheumatol"},{"issue":"December (6)","key":"10.1016\/j.atherosclerosis.2011.11.005_bib0055","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/j.1445-5994.1995.tb02870.x","article-title":"Dermatomyositis with lung involvement in a patient treated with simvastatin","volume":"25","author":"Hill","year":"1995","journal-title":"Aust N Z J Med"},{"issue":"November (853)","key":"10.1016\/j.atherosclerosis.2011.11.005_bib0060","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1136\/pgmj.72.853.694","article-title":"Lovastatin-associated dermatomyositis","volume":"72","author":"Rodriguez-Garcia","year":"1996","journal-title":"Postgrad Med J"},{"issue":"June (8)","key":"10.1016\/j.atherosclerosis.2011.11.005_bib0065","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/S0002-9343(01)00711-2","article-title":"Atorvastatin-induced dermatomyositis","volume":"110","author":"No\u00ebl","year":"2001","journal-title":"Am J Med"},{"issue":"December (6)","key":"10.1016\/j.atherosclerosis.2011.11.005_bib0070","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/mus.20127","article-title":"Dermatomyositis-like syndrome and HMG-CoA reductase inhibitor (statin) intake","volume":"30","author":"Vasconcelos","year":"2004","journal-title":"Muscle Nerve"},{"issue":"December (12 Pt 1)","key":"10.1016\/j.atherosclerosis.2011.11.005_bib0075","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/S0151-9638(05)79565-X","article-title":"Fluvastatin-induced dermatomyositis","volume":"132","author":"Thual","year":"2005","journal-title":"Ann Dermatol Venereol"},{"issue":"November (11)","key":"10.1016\/j.atherosclerosis.2011.11.005_bib0080","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.revmed.2005.07.005","article-title":"Pravastatin-induced dermatomyositis","volume":"26","author":"Zuech","year":"2005","journal-title":"Rev Med Intern"},{"issue":"June (6)","key":"10.1016\/j.atherosclerosis.2011.11.005_bib0085","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00105-008-1637-5","article-title":"Simvastatin-induced dermatomyositis","volume":"60","author":"Rasch","year":"2009","journal-title":"Hautarzt"},{"issue":"July (1)","key":"10.1016\/j.atherosclerosis.2011.11.005_bib0090","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1365-2133.2009.09205.x","article-title":"Simvastatin-induced amyopathic dermatomyositis","volume":"161","author":"Inhoff","year":"2009","journal-title":"Br J Dermatol"},{"issue":"February (7)","key":"10.1016\/j.atherosclerosis.2011.11.005_bib0095","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis (first of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"issue":"February (8)","key":"10.1016\/j.atherosclerosis.2011.11.005_bib0100","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM197502202920807","article-title":"Polymyositis and dermatomyositis (second of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"issue":"February (2)","key":"10.1016\/j.atherosclerosis.2011.11.005_bib0105","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.nmd.2006.10.007","article-title":"Progressive myopathy with up-regulation of MHC-I associated with statin therapy","volume":"17","author":"Needham","year":"2007","journal-title":"Neuromuscul Disord"},{"issue":"February (2)","key":"10.1016\/j.atherosclerosis.2011.11.005_bib0110","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/mus.21486","article-title":"Immune-mediated necrotizing myopathy associated with statins","volume":"41","author":"Grable-Esposito","year":"2010","journal-title":"Muscle Nerve"},{"issue":"September (9)","key":"10.1016\/j.atherosclerosis.2011.11.005_bib0115","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1002\/art.27572","article-title":"A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy","volume":"62","author":"Christopher-Stine","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"March (3)","key":"10.1016\/j.atherosclerosis.2011.11.005_bib0120","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/art.30156","article-title":"Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy","volume":"63","author":"Mammen","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.atherosclerosis.2011.11.005_bib0125","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/00131402-200103000-00003","article-title":"HMG-CoA reductase inhibitor myopathy: clinical, electrophysiological, and pathologic data in five patients","volume":"2","author":"Meriggioli","year":"2001","journal-title":"J Clin Neuromuscul Disord"},{"key":"10.1016\/j.atherosclerosis.2011.11.005_bib0130","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/jama.1990.03450010075034","article-title":"Myopathy and rhabdomyolysis associated with lovastatin\u2013gemfibrozil combination","volume":"264","author":"Pierce","year":"1990","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2011.11.005_bib0135","first-page":"295","article-title":"Rhabdomyolysis induced by simvastatin and ketoconazole treatment","volume":"22","author":"Gilad","year":"1999","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.atherosclerosis.2011.11.005_bib0140","doi-asserted-by":"crossref","first-page":"581","DOI":"10.7326\/0003-4819-137-7-200210010-00009","article-title":"Statin-associated myopathy with normal creatine kinase levels","volume":"137","author":"Phillips","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.atherosclerosis.2011.11.005_bib0145","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(03)14368-1","article-title":"Polymyositis and dermatomyositis","volume":"362","author":"Dalakas","year":"2003","journal-title":"Lancet"},{"issue":"April (4)","key":"10.1016\/j.atherosclerosis.2011.11.005_bib0150","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/s00415-003-1027-y","article-title":"Necrotising myopathy, an unusual presentation of a steroid-responsive myopathy","volume":"250","author":"Bronner","year":"2003","journal-title":"J Neurol"},{"issue":"March (3)","key":"10.1016\/j.atherosclerosis.2011.11.005_bib0155","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1212\/WNL.50.3.764","article-title":"Paraneoplastic necrotizing myopathy: clinical and pathological features","volume":"50","author":"Levin","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.atherosclerosis.2011.11.005_bib0160","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1378\/chest.08-0943","article-title":"Statins and interstitial lung disease: a systematic review of the literature and of Food and Drug Administration adverse event reports","volume":"134","author":"Fern\u00e1ndez","year":"2008","journal-title":"Chest"},{"issue":"March (2)","key":"10.1016\/j.atherosclerosis.2011.11.005_bib0165","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/01.md.0000209337.59874.aa","article-title":"Statin-associated myasthenia gravis: report of 4 cases and review of the literature","volume":"85","author":"Purvin","year":"2006","journal-title":"Medicine (Baltimore)"},{"issue":"January (1)","key":"10.1016\/j.atherosclerosis.2011.11.005_bib0170","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1468-3083.2006.01838.x","article-title":"Lupus erythematosus and other autoimmune diseases related to statin therapy: a systematic review","volume":"21","author":"No\u00ebl","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"November (6)","key":"10.1016\/j.atherosclerosis.2011.11.005_bib0175","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/00005792-199811000-00002","article-title":"Systemic immune reactions to HMG-CoA reductase inhibitors. Report of 4 cases and review of the literature","volume":"77","author":"Rudski","year":"1998","journal-title":"Medicine (Baltimore)"},{"issue":"September (8)","key":"10.1016\/j.atherosclerosis.2011.11.005_bib0180","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/00004836-200609000-00018","article-title":"Autoimmune hepatitis triggered by statins","volume":"40","author":"Alla","year":"2006","journal-title":"J Clin Gastroenterol"},{"issue":"February (2 Pt 1)","key":"10.1016\/j.atherosclerosis.2011.11.005_bib0185","first-page":"187","article-title":"Simvastatin-induced lichen planus pemphigoides","volume":"130","author":"Stoebner","year":"2003","journal-title":"Ann Dermatol Venereol"},{"issue":"March (1)","key":"10.1016\/j.atherosclerosis.2011.11.005_bib0190","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ecl.2008.11.002","article-title":"Managing statin myopathy","volume":"38","author":"Venero","year":"2009","journal-title":"Endocrinol Metab Clin N Am"},{"issue":"January (1)","key":"10.1016\/j.atherosclerosis.2011.11.005_bib0195","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.atherosclerosis.2008.05.021","article-title":"Molecular basis of statin-associated myopathy","volume":"202","author":"Vaklavas","year":"2009","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2011.11.005_bib0200","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2165\/00002018-200932010-00002","article-title":"Determinants of under-reporting of adverse drug reactions: a systematic review","volume":"32","author":"Lopez-Gonzalez","year":"2009","journal-title":"Drug Saf"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915011010744?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915011010744?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,12,17]],"date-time":"2021-12-17T00:25:49Z","timestamp":1639700749000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915011010744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S0021915011010744"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2011.11.005","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}